What could China's newly proposed foreign drug policy mean for multinational pharma companies, and how will it change the world’s second-largest pharma…

Johnson & Johnson has kept a positive attitude about its blockbuster immunology drug Remicade and the biosimilar competition it’s facing.

Takeda has finished enrolling 20,100 children for a massive phase 3 dengue vaccine study.

A rotavirus vaccine candidate showed better efficacy than Merck’s and GlaxoSmithKline’s approved vaccines in a late-stage trial.

The CDC is preparing a new avian influenza vaccine candidate amid an outbreak in China.

China’s BeiGene, which is developing a portfolio of immuno-oncology drugs, has struck a deal with a Chinese development agency to build a biologics plant to…

Takeda has partnered with digital health tools venture Cognition Kit to collect active and passive patient data for a deep dive on depression.

Astellas just forged a licensing deal with Affinivax to develop a pneumococcal vaccine. Their target? Pfizer’s Prevnar 13—the world’s best-selling vaccine.

ASLAN just rolled out positive top-line phase 2 data for its lead drug candidate varlitinib when combined with chemotherapy for the treatment of HER2-positive…

WuXi AppTec subsidiary STA has bulked up with a new pilot plant and a fresh batch of R&D scientists trained at the company’s Shanghai R&D site.

R&D